Bacterial resistance is one of the major world health problems. While there are already many compounds in clinical use that work by inhibiting peptidoglycan synthesis in subsequent steps, the initial steps of the synthesis pathway are still unexploited targets. One of these enzymes is MurA ligase, which catalyzes the first step of the peptidoglycan synthesis pathway.
Monoamine oxidase (MAO) is a mitochondrial enzyme that catalyzes the oxidative deamination of monoamines. In the body, it is present in two isoforms, MAO-A and MAO-B, which are different in the structure of active sites and substrates that they degrade. There are already several inhibitors in clinical use that differ in selectivity and are used in treatments of Parkinson’s, Alzheimer´s and other neurodegenerative diseases.
In this master´s thesis, we successfully synthesized eight compounds, which are analogs of two thiazoles that showed inhibitory activity on MurA when the library of covalent fragments was tested. The compounds differ in substituents bound to the thiazole ring. Microwave irradiation was used for most synthesis procedures instead of regular heating. The synthesis reactions included electrophilic and nucleophilic aromatic substitutions, Rosenmund-von Braun reaction, Suzuki and Stille coupling.
The previously synthesized hit compounds bounded to cysteine in the active site of enzyme MurA. Because the enzyme MAO also has cysteine in the active site, the successfully synthesized compounds were tested for inhibitory activity of MurA ligase, human MAO-A and MAO-B. The strongest inhibition of MurA ligase is shown by the compound, which has a bromine and pyridine group attached. Compound with carbonitrile and dimethylamine group attached to the ring is the most successful non-selective MAO inhibitor. The strongest selective MAO-B inhibition is shown by the compounds, which both have a phenyl group attached to the thiazoles ring.
We studied the effect of different thiazole ring substituents on inhibition of MurA ligase and both monoamine oxidase isoforms. Obtained compounds will represent basis for further development of thiazole-based compounds as potential active substances.
|